2019
DOI: 10.1155/2019/2121095
|View full text |Cite
|
Sign up to set email alerts
|

TLR4 Agonist Monophosphoryl Lipid A Alleviated Radiation-Induced Intestinal Injury

Abstract: The small intestine is one of the most sensitive organs to irradiation injury, and the development of high effective radioprotectants especially with low toxicity for intestinal radiation sickness is urgently needed. Monophosphoryl lipid A (MPLA) was found to be radioprotective in our previous study, while its effect against the intestinal radiation injury remained unknown. In the present study, we firstly determined the intestinal apoptosis after irradiation injury according to the TUNEL assay. Subsequently, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 37 publications
1
16
0
Order By: Relevance
“…However, we adopted the HINEG system, which can present the high flux of 14.1 MeV neutrons as to generate the mouse ARS model utilized here, to conquer this obstacle. Compared with our previous studies about ionizing photons protection, similar phenomena such as survival rate decline, body weight loss, critical organ shrinking, and hematopoietic tissue cell loss were also obvious in the neutron ARS model here [ 18 , 19 ]. The detriments by neutrons were much severer than that of photons, characterized by relatively low dose causing the similar outcomes and the advanced upcoming of injury peak, all of which promoted the insight of neutron biology at this condition.…”
Section: Discussionsupporting
confidence: 67%
“…However, we adopted the HINEG system, which can present the high flux of 14.1 MeV neutrons as to generate the mouse ARS model utilized here, to conquer this obstacle. Compared with our previous studies about ionizing photons protection, similar phenomena such as survival rate decline, body weight loss, critical organ shrinking, and hematopoietic tissue cell loss were also obvious in the neutron ARS model here [ 18 , 19 ]. The detriments by neutrons were much severer than that of photons, characterized by relatively low dose causing the similar outcomes and the advanced upcoming of injury peak, all of which promoted the insight of neutron biology at this condition.…”
Section: Discussionsupporting
confidence: 67%
“…Yang et al 17 studied the protective effect on Nrf2-deficient mice after receiving whole abdominal IR with 13 Gy γ-ray. Guo et al 5 used a model of 7 Gy whole body γ-ray to examine TLR4 agonist monophosphoryl lipid A-alleviated radiation-induced intestinal injury. In our study, the absence of crypts, a considerable loss of villi, and epithelial disruption were observed in the mouse models of radiation intestinal injury.…”
Section: Discussionmentioning
confidence: 99%
“…For example, different doses of 7, 8 or 9 Gy TBI were used in previous studies for exploring radiation-induced intestinal injury on C57BL/6 mice. 5 - 7 Moreover, doses between 12 and 20 Gy WAI were tested for mortality on C57BL/6 mice model, and the results show that animals started dying at doses of 12 Gy, 15 Gy or above 16 Gy. 8 In all, the different irradiation techniques, dose rate, and the age of the mice could induce different biological outcomes among C57BL/6 mice.…”
Section: Introductionmentioning
confidence: 99%
“…Extensive studies focus on the prevention and treatment of radio-induced intestinal injury, but no effective therapeutic measures appear so far [ 13 ]. Till now, the only FDA-approved radio-protective drug (WR2721, Amifostine, marketed as Ethyol® by Med Immune, Gaithersburg, MD) is used clinically [ 14 ], but still not free of toxicity. Hence, it is urgent to utilize a stable and reliable animal experimental model to deeply understand radio-induced intestinal injury.…”
Section: Introductionmentioning
confidence: 99%